Met Life Investment Management, LLC Regenxbio Inc. Transaction History

Met Life Investment Management, LLC

  • $16.6 Billion
  • Q2 2024

A detailed history of Met Life Investment Management, LLC transactions in Regenxbio Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 27,189 shares of RGNX stock, worth $285,212. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,189
Previous 20,449 32.96%
Holding current value
$285,212
Previous $430,000 26.05%
% of portfolio
0.0%
Previous 0.0%

Shares

42 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$11.51 - $21.53 $77,577 - $145,112
6,740 Added 32.96%
27,189 $318,000
Q1 2024

May 14, 2024
BUY
$12.17 - $24.61 $248,864 - $503,249
20,449 New
20,449 $430,000
Q2 2023

Apr 29, 2024
BUY
$17.23 - $21.71 $384,694 - $484,719
22,327 New
22,327 $446,000
Q1 2023

May 09, 2024
BUY
$18.08 - $24.55 $403,672 - $548,127
22,327 New
22,327 $422 Million
Q4 2022

May 10, 2024
SELL
$20.4 - $24.73 $19,074 - $23,122
-935 Reduced 4.02%
22,327 $506,000
Q4 2022

Mar 22, 2023
SELL
$20.4 - $24.73 $19,074 - $23,122
-935 Reduced 4.02%
22,327 $506,000
Q4 2022

Feb 15, 2023
SELL
$20.4 - $24.73 $19,074 - $23,122
-935 Reduced 4.02%
22,327 $506,000
Q3 2022

May 10, 2024
BUY
$22.29 - $35.04 $46,719 - $73,443
2,096 Added 9.9%
23,262 $614,000
Q3 2022

Jun 14, 2023
BUY
$22.29 - $35.04 $20,841 - $32,762
935 Added 4.19%
23,262 $614,000
Q3 2022

Mar 22, 2023
BUY
$22.29 - $35.04 $46,719 - $73,443
2,096 Added 9.9%
23,262 $614,000
Q3 2022

Nov 14, 2022
BUY
$22.29 - $35.04 $46,719 - $73,443
2,096 Added 9.9%
23,262 $615,000
Q2 2022

May 10, 2024
SELL
$19.35 - $35.04 $45,008 - $81,503
-2,326 Reduced 9.9%
21,166 $522,000
Q2 2022

Jun 20, 2023
SELL
$19.35 - $35.04 $22,465 - $40,681
-1,161 Reduced 5.2%
21,166 $522,000
Q2 2022

Mar 22, 2023
SELL
$19.35 - $35.04 $45,008 - $81,503
-2,326 Reduced 9.9%
21,166 $522,000
Q2 2022

Aug 11, 2022
SELL
$19.35 - $35.04 $45,008 - $81,503
-2,326 Reduced 9.9%
21,166 $523,000
Q1 2022

May 10, 2024
BUY
$24.62 - $34.31 $578,373 - $806,010
23,492 New
23,492 $779,000
Q1 2022

Jun 20, 2023
BUY
$24.62 - $34.31 $28,682 - $39,971
1,165 Added 5.22%
23,492 $779,000
Q1 2022

Mar 22, 2023
BUY
$24.62 - $34.31 $204,222 - $284,601
8,295 Added 54.58%
23,492 $779,000
Q1 2022

May 12, 2022
BUY
$24.62 - $34.31 $204,222 - $284,601
8,295 Added 54.58%
23,492 $780,000
Q4 2021

Jun 21, 2023
SELL
$30.19 - $40.28 $215,254 - $287,196
-7,130 Reduced 31.93%
15,197 $496,000
Q3 2021

Jun 21, 2023
SELL
$29.09 - $45.68 $207,411 - $325,698
-7,130 Reduced 31.93%
15,197 $637,000
Q2 2021

Jun 21, 2023
SELL
$32.46 - $40.48 $231,439 - $288,622
-7,130 Reduced 31.93%
15,197 $590,000
Q1 2021

May 17, 2024
SELL
$33.61 - $49.95 $176,519 - $262,337
-5,252 Reduced 25.68%
15,197 $518,000
Q1 2021

Jun 26, 2023
SELL
$33.61 - $49.95 $239,639 - $356,143
-7,130 Reduced 31.93%
15,197 $518 Million
Q4 2020

Jun 22, 2023
SELL
$26.52 - $49.35 $189,087 - $351,865
-7,130 Reduced 31.93%
15,197 $689,000
Q3 2020

Jun 26, 2023
SELL
$27.01 - $40.26 $192,581 - $287,053
-7,130 Reduced 31.93%
15,197 $418,000
Q2 2020

May 24, 2024
SELL
$27.75 - $43.44 $145,743 - $228,146
-5,252 Reduced 25.68%
15,197 $560 Million
Q2 2020

Jun 26, 2023
SELL
$27.75 - $43.44 $197,857 - $309,727
-7,130 Reduced 31.93%
15,197 $559,000
Q1 2020

Jul 12, 2023
SELL
$21.5 - $54.2 $153,295 - $386,446
-7,130 Reduced 31.93%
15,197 $492,000
Q4 2019

Jul 12, 2023
SELL
$34.54 - $44.87 $246,270 - $319,923
-7,130 Reduced 31.93%
15,197 $622,000
Q3 2019

Jul 12, 2023
SELL
$31.84 - $50.88 $227,019 - $362,774
-7,130 Reduced 31.93%
15,197 $541,000
Q3 2019

Mar 22, 2023
BUY
$31.84 - $50.88 $35,151 - $56,171
1,104 Added 7.83%
15,197 $541,000
Q3 2019

Nov 14, 2019
BUY
$31.84 - $50.88 $35,151 - $56,171
1,104 Added 7.83%
15,197 $541,000
Q2 2019

Jul 12, 2023
SELL
$42.0 - $59.29 $299,460 - $422,737
-7,130 Reduced 31.93%
15,197 $780,000
Q1 2019

Jul 13, 2023
SELL
$40.82 - $62.45 $336,111 - $514,213
-8,234 Reduced 36.88%
14,093 $807,000
Q4 2018

Jul 13, 2023
SELL
$39.11 - $75.15 $322,031 - $618,785
-8,234 Reduced 36.88%
14,093 $591,000
Q4 2018

Mar 22, 2023
SELL
$39.11 - $75.15 $311,784 - $599,095
-7,972 Reduced 36.13%
14,093 $591,000
Q4 2018

Feb 14, 2019
SELL
$39.11 - $75.15 $311,784 - $599,095
-7,972 Reduced 36.13%
14,093 $591,000
Q3 2018

Jul 13, 2023
SELL
$65.0 - $82.15 $535,210 - $676,423
-8,234 Reduced 36.88%
14,093 $1.06 Million
Q3 2018

Mar 22, 2023
SELL
$65.0 - $82.15 $17,030 - $21,523
-262 Reduced 1.17%
22,065 $1.67 Million
Q3 2018

Nov 14, 2018
BUY
$65.0 - $82.15 $575,120 - $726,863
8,848 Added 66.94%
22,065 $1.67 Million
Q4 2017

Feb 15, 2018
BUY
$26.0 - $34.6 $343,642 - $457,308
13,217
13,217 $439,000

Others Institutions Holding RGNX

# of Institutions
191
Shares Held
43.5M
Call Options Held
58.9K
Put Options Held
58.4K
View Full List

About REGENXBIO Inc.

RGNX Quotes by TradingView
  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $453M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email